Zurcher Kantonalbank (Zurich Cantonalbank) Morphic Holding, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $28 Billion
- Q1 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 4,585 shares of MORF stock, worth $156,210. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,585
Previous 4,585
-0.0%
Holding current value
$156,210
Previous $132,000
21.97%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MORF
# of Institutions
142Shares Held
37.9MCall Options Held
13.5KPut Options Held
190K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$160 Million0.42% of portfolio
-
Wellington Management Group LLP Boston, MA4.02MShares$137 Million0.03% of portfolio
-
Black Rock Inc. New York, NY3.28MShares$112 Million0.0% of portfolio
-
State Street Corp Boston, MA2.67MShares$90.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.52MShares$86 Million0.01% of portfolio
About Morphic Holding, Inc.
- Ticker MORF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,477,100
- Market Cap $1.31B
- Description
- Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...